Articles by Jeffrey Bouley

Different environmental exposures, different lifestyles, and so on. So they might have different weights or different styles or even different chronic diseases.

“Gene therapy has huge potential. It has already led to cures for conditions such as spinal muscular atrophy (SMA). In the future, we will be looking at conditions like motor neurone disease, Alzheimer’s and rare cancers,”

According to the company, the new data underscore the critical importance of identifying and treating SMA as early as possible.

Advances in genomics research increased the speed with which vaccines came to the fore to mitigate infection by the SARS-CoV-2 virus, thanks to early sequencing of the virus. Here is a quick roundup of some recent genomics news related to COVID-19.

Genomics, proteomics, and transcriptomics loom large in oncology

Making the rounds of brain-related therapeutic and diagnostic R&D, with a focus on neurodegenerative disease and dementia

The pandemic has not been good to us, but some good things might come out of it

March is still the month where we put extra attention on cancer, but the landscape is different in a pandemic

We explore advances in women’s cancers in addition to other recent oncology news

mRNA approaches vs. SARS-CoV-2, plus more news of infectious disease and cancer vaccines

Dealing with viruses, bacteria and other pathogens requires many approaches

With our first issue of 2021, we have lots of great changes to bring you

Get a look at what the Society for Laboratory Automation and Screening’s virtual annual meeting has to offer

A look at our new online venue for infectious diseases as well as upcoming coverage

ASCB|EMBO annual meeting goes virtual this year with cellular research. Two of the most significant changes aside from the online format are that the meeting will feature seven scientific tracks plus an education and professional development track, in addition to member-organized Special Interest Subgroups being held on three days of the meeting.